about
Laser-driven beam lines for delivering intensity modulated radiation therapy with particle beamsRadiolucent carbon-fiber reinforced pedicle screws for the treatment of spinal tumors: Advantages for radiation planning and follow-up imaging.Advanced treatment planning methods for efficient radiation therapy with laser accelerated proton and ion beams.Dosimetric effects of energy spectrum uncertainties in radiation therapy with laser-driven particle beams.Instrumentation for diagnostics and control of laser-accelerated proton (ion) beams.The effects of ultra-high dose rate proton irradiation on growth delay in the treatment of human tumor xenografts in nude mice.Assessment of secondary radiation and radiation protection in laser-driven proton therapy.Investigation of EBT2 and EBT3 films for proton dosimetry in the 4-20 MeV energy range.A treatment planning study to assess the feasibility of laser-driven proton therapy using a compact gantry design.A light-weight compact proton gantry design with a novel dose delivery system for broad-energetic laser-accelerated beams.Reduced volume SIB-IMRT/IGRT to head and neck cancer in elderly and frail patients: outcome and toxicity.Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol.Modelling of the oxygen enhancement ratio for ion beam radiation therapy.Future development of biologically relevant dosimetry.Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications.Individualized radiotherapy by combining high-end irradiation and magnetic resonance imaging.Quantification of the uncertainties of a biological model and their impact on variable RBE proton treatment plan optimization.Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse models.Matching the reaction-diffusion simulation to dynamic [18F]FMISO PET measurements in tumors: extension to a flow-limited oxygen-dependent model.Development and clinical evaluation of an ionization chamber array with 3.5 mm pixel pitch for quality assurance in advanced radiotherapy techniques.Paving the Road for Modern Particle Therapy - What Can We Learn from the Experience Gained with Fast Neutron Therapy in Munich?Local weighting of nanometric track structure properties in macroscopic voxel geometries for particle beam treatment planning.A phenomenological model for the relative biological effectiveness in therapeutic proton beams.Improved normal tissue protection by proton and X-ray microchannels compared to homogeneous field irradiation.Implications of free breathing motion assessed by 4D-computed tomography on the delivered dose in radiotherapy for esophageal cancer.Registration uncertainties between 3D cone beam computed tomography and different reference CT datasets in lung stereotactic body radiation therapy.Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.IMRT treatment planning for prostate cancer using prioritized prescription optimization and mean-tail-dose functions.Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons.Master of Science (MSc) Program in Radiation Biology: An Interdepartmental Course Bridging the Gap between Radiation-Related Preclinical and Clinical Disciplines to Prepare Next-Generation Medical Scientists.Speed optimized influence matrix processing in inverse treatment planning tools.Increased cell survival and cytogenetic integrity by spatial dose redistribution at a compact synchrotron X-ray source.Hybrid dose calculation: a dose calculation algorithm for microbeam radiation therapy.BioXmark for high-precision radiotherapy in an orthotopic pancreatic tumor mouse model : Experiences with a liquid fiducial marker.Interobserver variability of patient positioning using four different CT datasets for image registration in lung stereotactic body radiotherapy.SYRA3 COST Action--Microbeam radiation therapy: Roots and prospects.Optimization of radiobiological effects in intensity modulated proton therapy.Prioritized optimization in intensity modulated proton therapy.Prioritized efficiency optimization for intensity modulated proton therapy.Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons.
P50
Q26866538-08DDCE9F-4389-4D8A-B4D5-CB0542AB5B79Q33276492-9C1ADC90-11C6-44EB-AB0C-038D23AA0A6AQ33751246-CAB82929-22F7-444A-8600-D506C189BA45Q34157922-A36BE71E-B97B-4D6B-A7B0-0E0265711711Q35010639-BC511C37-7183-44A6-9150-C401256D7DDAQ35093876-889B5B74-F754-4371-AFDB-28334671D8E3Q35286382-5EE2D7D2-CE39-4464-BF55-F83CCD2CC7C8Q35540440-BCD59E24-96E5-4CA3-A74A-034D529E2945Q35761414-55A4A082-6F83-4094-B318-A01C0B5F3114Q36400408-749C1D85-6954-4D2A-A202-5251940F98F0Q37319558-9A082DE0-206B-4512-8E3D-FEECA66B1BA3Q37676732-911419EF-D7D6-4002-B9C8-F0D4B7087C0DQ37871737-B16961E3-FF79-4431-A2D5-13742EADD263Q38254486-9A0795C3-9CB0-40A5-84E2-355AB350A096Q38435486-4E636D2C-724D-4183-9B82-DB456C0D2A53Q38725176-C927F809-09FD-42F9-9B64-C33357BADC79Q38836481-6055DAE0-1459-4B3B-8F81-8596DF62A3C9Q39024526-917E688C-C445-4B24-A9C4-292F8EEC862CQ39038318-8BB1329D-9E90-438C-9762-AADFFA51701CQ39793418-9C3F7A13-5195-4C4A-91E0-615FB48EA701Q40238902-8C32CE22-0FDE-4C1E-B7FD-EC1D5B1C2ECDQ40328313-5B3E9D24-1388-4089-A976-FC59F388C167Q40530047-A56B9B70-0079-48D9-BF73-2DDDA40489EFQ40982955-40EB54A1-8E2C-4047-878A-205FADAD0645Q41289183-AC7C17D9-0A8C-4D2A-B122-7E63C5BDDC1EQ41582758-BB80628B-0416-4E42-9343-0E5D1E2D9F29Q41890284-4E7260CA-147D-4918-9FBF-9F4FF4D6F079Q41975928-8F6BB3F5-2E75-49BB-8FE6-94CAF2EE2D84Q42084247-CEE6A4A6-0A2D-44ED-BB8E-A4B19F984A16Q42364540-77E9B4C0-0D82-452C-AD50-5D46E32D4A43Q45026499-9F4904CE-5328-414C-8F07-C34363792769Q46355555-542FD885-3F09-4B33-97D9-D00AAD4A5BD5Q47565109-1392E271-BEA2-416A-B93E-D9F7A0FEA689Q47794575-0E8367A8-F739-4164-BB4D-D784E5DDD1C6Q47827484-9DAA2FB4-2F81-48C7-B317-E90CF998ECADQ48102837-06978AFD-C682-447D-B9A0-F26AACF9FCB0Q48952635-79E018DD-D59A-4453-B7E6-F80379FE3D57Q49100637-4A70F22B-4E92-4154-AF77-C752EDDA0C9BQ50553737-FE3ECB33-363C-4A4D-9071-4FF6F974A6B0Q50582468-CF073632-B8BC-4CE2-8FC2-66F71AA95FA3
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jan Jakob Wilkens
@ast
Jan Jakob Wilkens
@en
Jan Jakob Wilkens
@es
Jan Jakob Wilkens
@sl
type
label
Jan Jakob Wilkens
@ast
Jan Jakob Wilkens
@en
Jan Jakob Wilkens
@es
Jan Jakob Wilkens
@sl
prefLabel
Jan Jakob Wilkens
@ast
Jan Jakob Wilkens
@en
Jan Jakob Wilkens
@es
Jan Jakob Wilkens
@sl
P1053
A-2376-2011
P106
P1153
55868893100
P21
P31
P3829
P496
0000-0002-1851-0581